Pneumonia Vaccine (18 to 49 years old)

Am I eligible for this study?

To find out, please answer yes or no to the following questions.

 
 
Yes
 
No
1

Are you 18 to 49 years of age?

 

Overview

The purpose of the study is to determine safety and immunogenicity of a pneumonia vaccine for adults between 18 and 49 years of age who have not previously received a pneumonia vaccine. The study will last up to 7 months with up to 5 clinic visits and 2 telephone contacts. Qualified participants will receive study-related care and medication at no cost, and may be compensated for study-related time and travel.

Age
Gender
Condition
18 to 49 years of age
Male and Female
Pneumonia Vaccine

Why take part?

Participants will receive study-related doctor’s care, study medication at no cost. Compensation for study-related time and travel may be available.Millions of people lack the treatment they need to manage their conditions. As one of the largest and most recognized clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself.

Who is Synexus?

Synexus is a company dedicated to conducting clinical studies, and has been investigating the effectiveness of new study drugs and treatments for more than 20 years. We provide a friendly, relaxed environment in our own clinics where you have the chance to help shape the future of health for yourself and for others.We are sure you probably have more questions about the study, and we would be happy to take the time to give you more details.

All Synexus studies are approved by an independent ethics committee.

Recruiting at the following locations

 
Location
Location
 
Internal Medicine Associates Quick view

Still unsure?

Feel free to call us on to find out more about this study.

 

Your feedback is vital to the success of our research. Please fill in the form fields below.